The interleukin 21 pathway is critical for development of pathogenic antibodies in a chronic GVH model of SLE - Damphousse, C; Groves, C; Brown, T; Lowe, L; Nickerson-Nutter, C; Collins, M; Jr, O; Young, D (2006)